Preclinical evaluation of [(68)Ga]NOTA-pentixafor for PET imaging of CXCR4 expression in vivo — a comparison to [(68)Ga]pentixafor

BACKGROUND: Due to its overexpression in a variety of tumor types, the chemokine receptor 4 (CXCR4) represents a highly relevant diagnostic and therapeutic target in nuclear oncology. Recently, [(68)Ga]pentixafor has emerged as an excellent imaging agent for positron emission tomography (PET) of CXC...

Descripción completa

Detalles Bibliográficos
Autores principales: Poschenrieder, Andreas, Schottelius, Margret, Schwaiger, Markus, Wester, Hans-Jürgen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031577/
https://www.ncbi.nlm.nih.gov/pubmed/27655427
http://dx.doi.org/10.1186/s13550-016-0227-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031577/
https://www.ncbi.nlm.nih.gov/pubmed/27655427
http://dx.doi.org/10.1186/s13550-016-0227-2

Ejemplares similares